177 related articles for article (PubMed ID: 30973283)
1. Glomerular expression of matrix metalloproteinases in systemic lupus erythematosus in association with activity index and renal function.
Adamidis KN; Kopaka ME; Petraki C; Charitaki E; Apostolou T; Christodoulidou C; Nikolopoulou N; Giatromanolaki A; Vargemesis V; Passadakis P
Ren Fail; 2019 Nov; 41(1):229-237. PubMed ID: 30973283
[TBL] [Abstract][Full Text] [Related]
2. Expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of matrix metalloproteinases 2 and 1 in the glomeruli of human glomerular diseases: the results of studies using immunofluorescence, in situ hybridization, and immunoelectron microscopy.
Sekiuchi M; Kudo A; Nakabayashi K; Kanai-Azuma M; Akimoto Y; Kawakami H; Yamada A
Clin Exp Nephrol; 2012 Dec; 16(6):863-74. PubMed ID: 22614167
[TBL] [Abstract][Full Text] [Related]
3. Glomerular expression of matrix metalloproteinases in AL-amyloidosis and association with renal function at the time of kidney biopsy.
Charitaki E; Kastritis E; Petraki C; Liapis K; Adamidis K; Apostolou T; Christodoulidou C; Nikolopoulou N; Terpos E; Nakopoulou L; Dimopoulos MA
Clin Nephrol; 2016 Jan; 85(1):44-54. PubMed ID: 26587779
[TBL] [Abstract][Full Text] [Related]
4. Renal expression of matrix metalloproteinases in human ANCA-associated glomerulonephritis.
Sanders JS; van Goor H; Hanemaaijer R; Kallenberg CG; Stegeman CA
Nephrol Dial Transplant; 2004 Jun; 19(6):1412-9. PubMed ID: 15034162
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase-2 and -9 activity levels increase in cutaneous lupus erythematosus lesions and correlate with disease severity.
Ertugrul G; Keles D; Oktay G; Aktan S
Arch Dermatol Res; 2018 Mar; 310(2):173-179. PubMed ID: 29349515
[TBL] [Abstract][Full Text] [Related]
6. Urinary matrix metalloproteinases reflect renal damage in anti-neutrophil cytoplasm autoantibody-associated vasculitis.
Sanders JS; Huitema MG; Hanemaaijer R; van Goor H; Kallenberg CG; Stegeman CA
Am J Physiol Renal Physiol; 2007 Dec; 293(6):F1927-34. PubMed ID: 17898039
[TBL] [Abstract][Full Text] [Related]
7. Glomerular distribution and gelatinolytic activity of matrix metalloproteinases in human glomerulonephritis.
Urushihara M; Kagami S; Kuhara T; Tamaki T; Kuroda Y
Nephrol Dial Transplant; 2002 Jul; 17(7):1189-96. PubMed ID: 12105240
[TBL] [Abstract][Full Text] [Related]
8. Histological predictors of renal outcome in lupus nephritis: the importance of tubulointerstitial lesions and scoring of glomerular lesions.
Obrișcă B; Jurubiță R; Andronesi A; Sorohan B; Achim C; Bobeica R; Gherghiceanu M; Mandache E; Ismail G
Lupus; 2018 Aug; 27(9):1455-1463. PubMed ID: 29759047
[TBL] [Abstract][Full Text] [Related]
9. Differential expression profiling of matrix metalloproteinases and tissue inhibitors of metalloproteinases in females with or without pelvic organ prolapse.
Wang X; Li Y; Chen J; Guo X; Guan H; Li C
Mol Med Rep; 2014 Oct; 10(4):2004-8. PubMed ID: 25110112
[TBL] [Abstract][Full Text] [Related]
10. Cutis laxa: analysis of metalloproteinases and extracellular matrix expression by immunohistochemistry and histochemistry.
Gu W; Liu W; Yang X; Yuan X; Tian Y; Meng R; Zhao Q
Eur J Dermatol; 2011; 21(5):717-21. PubMed ID: 21719403
[TBL] [Abstract][Full Text] [Related]
11. Glomerular protein levels of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 are lower in diabetic subjects.
Cornish TC; Bagnasco SM; Macgregor AM; Lu J; Selvin E; Halushka MK
J Histochem Cytochem; 2009 Nov; 57(11):995-1001. PubMed ID: 19506087
[TBL] [Abstract][Full Text] [Related]
12. Analysis of clinicopathologic correlations in Iranian patients with lupus nephritis.
Shariati-Sarabi Z; Ranjbar A; Monzavi SM; Esmaily H; Farzadnia M; Zeraati AA
Int J Rheum Dis; 2013 Dec; 16(6):731-8. PubMed ID: 24382282
[TBL] [Abstract][Full Text] [Related]
13. [Immunohistochemical localization of matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinases (TIMP) in tuberculous pleuritis].
Hoheisel G; Sack U; Hui DS; Lai F; Chan KS; Choi CH; Schauer J; Tannapfel A
Pneumologie; 2004 May; 58(5):305-8. PubMed ID: 15162254
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinases and mesangial remodeling in light chain-related glomerular damage.
Keeling J; Herrera GA
Kidney Int; 2005 Oct; 68(4):1590-603. PubMed ID: 16164636
[TBL] [Abstract][Full Text] [Related]
15. The imbalanced expression of matrix metalloproteinases in nephrogenic systemic fibrosis.
Kelly BC; Markle LS; Vickers JL; Petitt MS; Raimer SS; McNeese C
J Am Acad Dermatol; 2010 Sep; 63(3):483-9. PubMed ID: 20708474
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinases, their tissue inhibitors and colorectal cancer staging.
Baker EA; Bergin FG; Leaper DJ
Br J Surg; 2000 Sep; 87(9):1215-21. PubMed ID: 10971431
[TBL] [Abstract][Full Text] [Related]
17. Increased acinar damage of salivary glands of patients with Sjögren's syndrome is paralleled by simultaneous imbalance of matrix metalloproteinase 3/tissue inhibitor of metalloproteinases 1 and matrix metalloproteinase 9/tissue inhibitor of metalloproteinases 1 ratios.
Pérez P; Kwon YJ; Alliende C; Leyton L; Aguilera S; Molina C; Labra C; Julio M; Leyton C; González MJ
Arthritis Rheum; 2005 Sep; 52(9):2751-60. PubMed ID: 16142742
[TBL] [Abstract][Full Text] [Related]
18. [Reference ranges of matrix metalloproteinase-1, -2, -9 and tissue inhibitor of matrix metalloproteinases-1 concentrations in amniotic fluid in physiological pregnancy].
Korenovsky YV; Remneva OV
Biomed Khim; 2016; 62(1):96-8. PubMed ID: 26973196
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in sera and tissue of patients with Dupuytren's disease.
Ulrich D; Hrynyschyn K; Pallua N
Plast Reconstr Surg; 2003 Oct; 112(5):1279-86. PubMed ID: 14504511
[TBL] [Abstract][Full Text] [Related]
20. Diabetes may affect the expression of matrix metalloproteinases and their inhibitors more than smoking in chronic periodontitis.
Bastos MF; Tucci MA; de Siqueira A; de Faveri M; Figueiredo LC; Vallim PC; Duarte PM
J Periodontal Res; 2017 Apr; 52(2):292-299. PubMed ID: 27363729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
